Literature DB >> 16364083

Serum lipid pattern in chronic hepatitis C: histological and virological correlations.

D Siagris1, M Christofidou, G J Theocharis, N Pagoni, C Papadimitriou, A Lekkou, K Thomopoulos, I Starakis, A C Tsamandas, C Labropoulou-Karatza.   

Abstract

Lipoproteins are closely connected to the process of hepatitis C virus (HCV) infection. The aim of this study was to evaluate the lipaemic profile in patients with chronic HCV infection, and to identify any association between serum lipid levels and viral load, HCV genotype or liver histology. Total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C) and triglycerides (TG) were measured in the sera of 155 patients with chronic HCV infection and 138 normal subjects, matched for age and sex. Viral parameters and liver histology were evaluated in HCV-infected patients. Serum TC (P < 0.0005), HDL-C (P < 0.0005) and LDL-C (P < 0.0005) were lower in chronic hepatitis C patients compared with controls. Grading score was positively correlated with TC and LDL-C. Patients with HCV genotype 3a had significantly lower levels of TC, HDL-C, LDL-C, higher viral load and higher frequency of hepatic steatosis than those with other genotypes. Logistic regression analysis identified genotype 3a (OR, 6.96; 95% CI, 2.17-22.32, P = 0.0011) as the only significant predictive variable associated with low serum cholesterol concentration. HCV infection is associated with clinically significant lower cholesterol levels (TC, LDL and HDL) when compared with those of normal subjects. This finding is more pronounced in patients infected with HCV genotype 3a. Further studies are necessary to define the pathophysiology of the relationship between lipid metabolism and HCV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16364083     DOI: 10.1111/j.1365-2893.2005.00655.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  44 in total

1.  Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C.

Authors:  Yumi Kobayashi; Yasunori Kawaguchi; Toshihiko Mizuta; Takuya Kuwashiro; Satoshi Oeda; Noriko Oza; Hirokazu Takahashi; Shinji Iwane; Yuichiro Eguchi; Keizo Anzai; Iwata Ozaki; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2010-11-03       Impact factor: 7.527

2.  Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.

Authors:  Lance D Presser; Steven McRae; Gulam Waris
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 3.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

4.  Differences in the factors associated with serum viral load between genotypes 1 and 2 in patients with chronic hepatitis C.

Authors:  Shunsuke Sato; Takuya Genda; Katsuharu Hirano; Hironori Tsuzura; Yoshio Kanemitsu; Yutaka Narita; Tetsu Kikuchi; Katsuyori Ijima; Takafumi Ichida
Journal:  Hepatol Int       Date:  2011-04-02       Impact factor: 6.047

5.  Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

Authors:  Josephine H Li; Xiang Qian Lao; Hans L Tillmann; Jennifer Rowell; Keyur Patel; Alexander Thompson; Sunil Suchindran; Andrew J Muir; John R Guyton; Stephen D Gardner; John G McHutchison; Jeanette J McCarthy
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

6.  Metabolic profiles in patients with chronic hepatitis C: a case-control study.

Authors:  Ching-Sheng Hsu; Chun-Jen Liu; Chen-Hua Liu; Chi-Ling Chen; Ming-Yang Lai; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2008-02-28       Impact factor: 6.047

Review 7.  Hepatitis C virus infection: Are there still specific problems with genotype 3?

Authors:  Claire Gondeau; Georges Philippe Pageaux; Dominique Larrey
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

8.  The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high-risk Hispanic population.

Authors:  J E Forrester; B H McGovern; M S Rhee; R K Sterling
Journal:  HIV Med       Date:  2009-06-01       Impact factor: 3.180

9.  Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion.

Authors:  Pablo Gastaminza; Guofeng Cheng; Stefan Wieland; Jin Zhong; Wei Liao; Francis V Chisari
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

Review 10.  Using high-throughput genomics to study hepatitis C: what determines the outcome of infection?

Authors:  Kathie-Anne Walters; Michael G Katze
Journal:  Antiviral Res       Date:  2009-01-07       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.